Laura Blaha PhD

Laura Blaha, PhD, is currently a Principal Scientist at Sanofi, where they focus on analytics and automation for cell and genome engineering. Previously, Laura worked at Biogen as a Postdoctoral Researcher from 2017 to 2021, where they led research on the impact of ApoE on Alzheimer's disease and contributed to multiple publications. They also served as a Scientist II at Editas Medicine from 2021 to 2022, managing a team and developing cell-based assays for immuno-oncology cell therapy. Laura's educational background includes a Bachelor of Science and a PhD in Biomedical Engineering from Boston University.